Relief Therapeutics Holding SA announced the formation of its new executive committee strengthening its capabilities with the appointment of several new members, including chief human resources officer and head of legal and compliance. Melinda Keeganjoins the executive committee in the newly created role of chief human resources officer. Ms. Keegan brings over 20 years of HR life sciences experience building and leading companies from the initial startup phase and scaling through commercialization.

Her expertise includes all aspects of human resource activities, including talent management, culture building, and leadership development. Ms. Keegan joined Relief in 2022 on a consulting basis and played a crucial role in supporting the Company across all HR matters. She holds a master of science in organizational development and is certified as a senior professional in human resources (SPHR).

Giorgio Reinerhas been promoted to the newly created role of chief scientific officer. With over 30 years of R&D experience, Mr. Reiner has been serving as corporate director of research and development with APR Applied Pharma Research SA (APR) since 2000. Following Relief's acquisition of APR in 2021, he has led the development of the group's pharmaceutical technologies and new products.

Mr. Reiner holds a master's degree in pharmaceutical chemistry and technology from the University of Pharmacy in Milan, Italy. Paolo Galfetti, Relief's current chief operating officer, transitions to the role of chief business officer, a move reflective of the new strategic requirements of the organization. Mr. Galfetti will maintain many of his current internal responsibilities and will prioritize driving business development initiatives.

Mr. Galfetti is a Chartered Financial Analyst (CFA) and has a bachelor's degree in economics from the Commercial University Bocconi, Milan, Italy. Vincenzo Gallo has been newly appointed head of legal and compliance. Mr. Gallo has over 10 years' legal expertise in the pharmaceutical industry, gained in both large international and start-up corporations.

He worked as senior legal counsel at CHEMO (industrial division of Insud Pharma Group) and joined APR as corporate legal counsel in 2020. Following Relief's acquisition of APR in 2021, Mr. Gallo has overseen varied legal matters at Relief. Mr. Gallo holds a master's degree in law.

All executive committee appointments are approved by the Board of Directors and effective immediately.